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This study is the seventh report on fatal poisonings among drug addicts in the Nordic countries. In 
this report, we analyse data from the five Nordic countries: Denmark, Finland, Iceland, Norway and 
Sweden. Data on gender, number of deaths, places of deaths, age, main intoxicants and substances 
detected in blood were recorded to obtain national and comparable Nordic data, and to allow 
comparison with earlier studies conducted in 1984, 1991, 1997, 2002, 2007 and 2012. 
The death rate (number of deaths per 100,000 inhabitants) was highest in Iceland (6.58) followed 
closely by Sweden (6.46) and then lowest in Denmark (4.29). The death rate increased in Finland 
(5.84), Iceland and Sweden and decreased in Denmark compared to earlier studies. The death rate in 
Norway, which has decreased since 2002, has stabilised around 5.7 as of 2017. Women accounted 
for 7–23% of the fatal poisonings. The percentage was lowest in Iceland and highest in Finland and 
Norway. The age range was 14 to 70 years. The median age (41 years) was highest in Denmark and 
Norway. The other countries had a median age between 33 and 35 years. 
Opioids were the main cause of death. Methadone remained the main intoxicant in Denmark, while 
heroin/morphine was still the main intoxicant in Norway, as was buprenorphine in Finland. 
However, the picture has changed in Sweden compared to 2012, where heroin/morphine caused 
most deaths in 2017. Sweden also experienced the highest number of deaths from fentanyl 
analogues (67 deaths) and buprenorphine (61 deaths). Deaths from fentanyl analogues also occurred 
in Denmark, Finland and Norway, but to a smaller extent. Over the years, the proportion of opioid 
deaths has decreased in all countries except Sweden, which has experienced an increase. This 
decline has been replaced by deaths from CNS stimulants like cocaine, amphetamine and 
methylenedioxymethamphetamine (MDMA). Cocaine deaths have occurred in all countries but 
most frequently in Denmark. MDMA deaths have increased in all countries but mostly in Finland. 
 
Poly-drug use was widespread, as seen in the earlier studies. The median number of detected drugs 
per case varied from 4–6. Heroin/morphine, methadone, buprenorphine, cocaine, amphetamine, 
methamphetamine, MDMA, tetrahydrocannabinol (THC) and benzodiazepines were frequently 
detected. Pregabalin and gabapentin were detected in all countries, especially pregabalin, which was 
detected in 42% of the Finnish cases. New psychoactive substances (NPS) occurred in all countries 
except Iceland.  
 
Highlights 
• Finland had a different drug profile compared to the other countries. 
• Opioids were the main cause of death among fatal poisoned drug addicts in all countries. 
• Cocaine and MDMA deaths increased in all countries. 
• Sweden saw a high number of deaths from fentanyl analogues. 
• New psychoactive substances have emerged in all countries except Iceland. 
 





According to the World Drug Report 2019, the severity and complexity of the world drug situation 
is increasing [1]. During the last decade, drug overdose deaths have continued to rise in Europe and, 
even more prominently, in North America. Opioids, often in combination with other substances, are 
present in the majority of fatal overdoses reported in Europe. Heroin remains the major illicit 
opioid, but methadone, buprenorphine, fentanyl and new synthetic opioids are increasingly involved 
[2]. The average mortality rate due to overdoses in Europe in 2017 is estimated at 22.6 deaths per 
million in the population aged 15–64, but this is likely to be an underestimation [2,3]. In the United 
States, synthetic opioids, primarily illicit fentanyl, surpassed prescription opioids in 2016 as the 
most common drugs involved in overdose deaths [4], and the drug overdose mortality rates in the 
US are now 3.5 times higher than in its peer countries (Denmark, Finland, United Kingdom, 
Australia etc.) [5]. 
The Nordic Countries – Denmark, Finland, Iceland, Norway and Sweden – report among the 
highest drug overdose mortality rates in Europe and some other Northern European countries, with 
more than 40 deaths per million inhabitants per year. The above average quality of forensic and 
toxicological investigation in the Nordic Countries at the European level, because of the reliable 
data produced, provides a better understanding of drug trends and health threats in the area [2,6]. 
Fugelstad et al. [7] have pointed out that statistics based on forensic toxicology are more complete, 
provide more detail on abused substances and are usually available earlier than national mortality 
register–based statistics. 
A working group of investigators representing the Nordic forensic authorities has been closely 
following the trends of fatal drug poisonings in the Nordic Countries over the course of 35 years. A 
remarkable series of previously published Nordic studies is available, covering the years 1984, 
 
1991, 1997, 2002, 2007 and 2012, and all use the same definition for the term drug addict [8-13]. 
Interestingly, in 1984, drug addicts accounted for 62% of all fatal intoxications in the Danish data, 
while the corresponding figures were 33% in the Norwegian, 16% in the Swedish and 5% in the 
Finnish data, and no deaths of drug addicts were found in Iceland [8]. Over the years, the death 
rates of drug addicts among the Nordic Countries have become more homogeneous. Nevertheless, 
significant differences in the principal toxic drugs have remained, with various opioids being the 
predominant agents [13]. 
In the present follow-up study, we investigate the fatal intoxications in Nordic drug addicts in 2017 
and compare the results with those of the previous studies using the established tables and figures. 
As earlier, the special forensic toxicology register–based information comprises poisoning mortality 
statistics, age distribution and a detailed account of the drugs of abuse that were involved.  
 
2. Materials and methods 
This study analysed data on fatal poisonings in drug addicts that were submitted for medico-legal 
autopsy and toxicological analysis in the five Nordic countries in 2017. A few medical autopsies 
were also included. These data were compared with similar findings reported in 1991, 1997, 2002, 
2007 and 2012. A drug addict was defined as ‘‘a person who, according to information from the 
police and/or autopsy report, is known to have abused drugs intravenously and/or abused the drugs 
listed in the Single Convention on Narcotic Drugs 1961, schedule I, and/or the International 
Convention on Psychotropic Substances 1971, schedules I and II’’. 
In almost all cases, except for a few in which suitable material was not obtained at autopsy, 
screening was performed for opiates, methadone, other opioids, amphetamines, cocaine, THC and 
 
benzodiazepines. Additional drugs detected by the screening procedure or at the special request of 
the police were recorded, and the blood alcohol concentrations (BAC) were routinely determined. 
The cause of death according to the autopsy report was systematically recorded, along with 
toxicological findings, police information about the deceased and the circumstances surrounding the 
death. Drugs and poisons were divided into four groups: 
Group I: Drugs listed in the Single Convention on Narcotic Drugs 1961, schedule I (cocaine, 
fentanyl, heroin/morphine, methadone, oxycodone etc.) and schedule II (codeine, etc.). 
Tramadol, mitragynine and terpentadol were included because of their classification as 
opioids. Fentanyl analogues were also included in this group. 
Group II: Drugs listed in the International Convention on Psychotropic Substances 1971, schedules 
I and II (amphetamine, methamphetamine, MDMA, GHB, methylphenidate, THC etc.). 
NPS (3-MeO-PCP, 5-APB, synthetic cannabinoids etc.) were also included in this group. 
Ketamine was included in this group. 
Group III: Drugs listed in the International Convention on Psychotropic Substances 1971, schedules 
III and IV (benzodiazepines, buprenorphine, barbiturates, zolpidem etc.). Zopiclone was 
included because of its classification as a substance related to benzodiazepines. 
Group IV: All other drugs and poisons, including ethanol. 
Buprenorphine is an opioid and is therefore included in the comparison of opioid deaths. The  
number of opioid deaths is calculated per 100,000 inhabitants in the age group 15-64 in each Nordic  
country for the sake of comparison between the countries in figure 3. 
Deaths caused by poisoning were recorded according to the drug that a forensic pathologist judged 
to be the main intoxicant. In cases involving multiple drugs in which the cause of death could not be 
 
ascribed to a single substance, the drug with the lowest group number (see above) was considered 
the main intoxicant. Cases involving two or more drugs in the same group were recorded according 
to the drug judged to be the main contributor to death. 
Heroin is rapidly metabolised to 6-monoacetylmorphine and further to morphine. Consequently, if 
6-monoacetylmorphine was not detected, it was impossible to determine on the basis of the analysis 
whether heroin or morphine was used. However, heroin intake was often indicated in police reports. 
In the present study, fatal intoxication by heroin/morphine was verified by the presence of morphine 
in the blood and, in many cases, also by the presence of 6-monoacetylmorphine in a biological 
specimen (usually blood or urine). 
All laboratories participate in more than one international proficiency testing scheme relevant for 
the forensic analysis. 
All findings, after primary screening by immunological analysis, gas chromatography (GC), 
GCMS, liquid chromatography (LC), UPLC–TOF-MS, and (UP)LC/MS, were confirmed and 
quantified by specific (UP)LC- and GC-chromatography methods. 
All age groups (14–70 years) were included in the study. The death rate in each country was 
calculated as the number of deaths per 100,000 inhabitants in the 15–64 year age group, as the 
addicts were, with few exceptions, younger than 65 years old. Poisson distribution with 95% CI is 
used in Fig. 1. 
Due to its low number of deaths, Iceland was sometimes considered and discussed separately, and 
comparisons were performed mainly for the other four countries. 
2.1. Ethical issues 
 
The Danish part of the study was approved by The Danish Data Protection Agency. The National 
Committee on Health Research Ethics in Denmark was informed about the Danish part of the study 
and determined that the survey did not need to be reported to the Committee. Only anonymised data 
is presented.  
According to the Finnish legislation, no separate ethical approval is needed for studies that utilise 
de-identified register-based data (Personal Data Act 523/1999). Permission to use data was obtained 
from the maintainer of the register (Finnish Institute for Health and Welfare). 
The Icelandic part of the study was approved by the Icelandic National Bioethics Committee (VSN-
18-194), by the Icelandic Data Protection Authority and by the Directorate of Health, including the 
National Death Registry. 
The Norwegian part of the study was approved by the Regional Committees for Medical and Health 
Research Ethics, Norway, 2017/2474/REK sør-øst C and by the Public Prosecutor at the Office of 
the Director of Public Prosecutions, 2017/01269-005 BIS/ggr 639.2. Only anonymised data is 
presented. 
The Swedish part of the study was approved by the Regional Ethics Review Board in Linköping 
Sweden, before start (Dnr 2016/489-31). 
 
3. Results 
3.1. Death rates 
Figure 1 shows the death rate per 100,000 inhabitants for all the Nordic countries from 1991 to 
2017. The death rate increased in Finland, Iceland and Sweden in 2017 compared to 2012, and 
decreased in Denmark and Norway. The death rate has been relatively stable in Denmark, with 
 
variations from 6.54 in 1997 to 5.19 in 2012. In 2017, the death rate (4.29) in Denmark was at its 
lowest level compared to the earlier years and also to the other countries. In Finland, the death rate 
has increased since 1991, from 1.16 to 5.84 during these years. A similar increase was seen in 
Iceland, where the death rate was 0.64 in 1991 and 6.58 in 2017. In 2017, Iceland and Sweden had 
the highest death rates among the Nordic countries for the first time during the observed period. In 
Norway, the number has decreased since 2002, and 2017 was the first year in 20 years where 
Norway did not have the highest death rate of the Nordic countries. The death rate in Sweden 
increased, similarly to Finland and Iceland, from 1.53 in 1991 to 6.46 in 2017.  
3.2. Places of death 
The percentage of fatal poisonings among drug addicts in the capital and suburbs were similar in 
Denmark (29 %), Finland (26 %), Norway (30 %) and Sweden (29 %) and comparable to earlier 
years. The percentage of each country’s population that live in this region is relatively similar as 
well. In Iceland, however, where a larger proportion of the population lives in the capital area, 87 % 
of the deaths occurred in the capital and suburbs. For all countries, more than 83 % of the deaths 
occurred indoors.  
3.3. Distribution of deaths by gender and age 
Fatal poisonings in the Nordic countries in 2017 mainly occurred in men; the percentages of women 
were 15 % (Denmark), 23 % (Finland and Norway), 17 % (Sweden) and 7 % (Iceland). These 
percentages were similar to those registered in 2012, with some differences for Finland, Denmark 
and Iceland [13]. 
The age ranges of the fatally poisoned drug addicts were 16–70 years (Denmark), 17–65 years 
(Finland), 14–68 years (Norway), 17–68 years (Sweden) and 20–41 years (Iceland). The mean and 
median ages were similar within each country. The median age in 2017 was 41 years for Denmark, 
 
35 years for Finland, 41 years for Norway, 33 years for Sweden and 34 years for Iceland. In 
comparison to earlier years, the difference in median age between the Nordic countries is getting 
smaller [13]. The median age of the fatally poisoned drug addicts has increased in Finland and 
Norway and was almost unchanged in the other countries. Figure 2 shows that the highest death rate 
for Denmark and Finland was in the group aged 35–39 years, whereas in Norway, it was highest in 
the group aged 30–34 years and almost as high in the group aged 55–59 years. In Sweden, the 
highest death rate was observed in the group aged 25–29 years, although it was almost as high in 
the group aged 30–34 years. 
3.4. Cause of death/main intoxicant 
The main intoxicants in the included drug addict deaths for all five Nordic countries are shown in 
Table 1; the three previous investigations 2002, 2007 and 2012 are included for comparison. 
Group I drugs dominated as the main intoxicants in Denmark (90%), Norway (76%) and Sweden 
(72%) in 2017. Conversely, the proportion of fatal poisonings due to Group I drugs (35%) was 
almost at the same level as fatal poisonings due to Group III drugs (36%) in Finland, which is due 
to the high amount of buprenorphine intoxications.  
Opioids including buprenorphine (Group III) were the most prevalent cause of death; these are 
illustrated in Figure 3. Overall, compared to earlier investigations, fatal poisonings due to opioids 
decreased in Denmark and Norway, but opioids were still the main intoxicants, with 3.5 cases and 
4.5 cases per 100,000 inhabitants, respectively, in 2017. Finland and Sweden saw an increase in 
opioid intoxications, with 3.3 cases and 5.4 cases per 100,000 inhabitants observed, respectively, in 
2017. On the contrary, when looking at the proportion of opioid deaths among all fatally poisoned 
drug addicts, Finland saw a decrease from 62% in 2012 to 55 % in 2017, and the decreasing trend 
continued in the proportion of opioid deaths observed since 1997 in Denmark (82%) and Norway 
 
(77%). Furthermore, the trend toward an increase in opioid deaths observed since 2002 continued in 
Sweden (84%) in 2017. Regarding deaths caused by specific opioids, heroin/morphine has shown a 
decreasing trend in Denmark and Norway over the years, while the numbers have fluctuated over 
time in Sweden. Heroin/morphine was the most common main intoxicant in both Sweden and 
Norway in 2017. Intoxications by heroin/morphine almost disappeared in Finland in 2007 and have 
been continuously low in the follow-up studies.  
Fatal poisonings with methadone have decreased since 2012, but it was still the most common main 
intoxicant in Denmark in 2017 (Table 1). In Finland, however, a small increase was observed in 
intoxications due to methadone.  
Oxycodone deaths showed a threefold rise compared to 2012 in Finland and was the second most 
common intoxicant in 2017. Deaths due to oxycodone increased in all the Nordic countries. 
Intoxications due to tramadol were still high in Finland and Sweden. Fentanyl deaths decreased in 
Finland and Sweden but increased in the other Nordic countries. Deaths by codeine have declined in 
all countries except in Norway.  
Included in the Group I drugs were also a considerable number of deaths due to fentanyl analogues, 
e.g. 52 fatal intoxications of cyclopropylfentanyl in Sweden alone. Deaths by fentanyl analogues 
were also seen in Denmark, Finland and Norway. Carfentanil deaths occurred in Finland, Norway 
and Sweden. Three deaths from the opioid U-47700 occurred in Finland and Sweden (Table 1). 
This increase in deaths due to other opioids can also be seen in Figure 3, for all the Nordic 
countries, when related to the number of inhabitants. This graph includes other opioids, mainly 
oxycodone and tramadol, besides the fentanyl analogues.  
A little more than half of the fatal intoxications in Iceland were due to opioids, mostly fentanyl and 
oxycodone.  
 
Since 2012 there was also a notable increase of cocaine intoxications in all the Nordic countries, 
especially in Denmark. 
Group II drug intoxications have increased over the years in all countries except Sweden, Table 1. 
Amphetamine intoxications were most frequently seen in Finland, while a notable increase occurred 
overall in deaths due to MDMA. Methamphetamine poisonings were seen in all countries except 
Denmark but most frequently in Finland and Norway. Six deaths occurred due to NPS in group II; 
these were seen in Finland, Norway and Sweden. GHB as cause of death was only seen in Finland 
and Norway, while there was one single fatal intoxication with methylphenidate in Iceland. 
Group III drugs as main intoxicants were significant in Finland, but an increase of deaths due to 
group III drugs was seen overall. In accordance with our previous publications, buprenorphine was 
the single most frequent cause of death in Finland in 2017. The number of buprenorphine 
intoxications has increased in all the Nordic countries, and especially in Sweden; where it was the 
second main intoxicant after heroin/morphine.  
Fatal intoxications with benzodiazepines were seen in all countries except Iceland; these included 
non-prescription benzodiazepines in Denmark (flubromazolam) and Sweden (norfludiazepam). 
Other causes of death were pregabalin and gabapentin in Finland, Sweden and Norway. 
Group IV drugs still constituted 7 to 8% of the fatal intoxications in Finland and Sweden, similar to 
what was seen in 2012, while group IV drugs decreased to 2% in Denmark but increased to 3% in 
Norway. This group consists of different pharmaceutical drugs, poisons and alcohols. Norway saw 
one death from lighter gas. Intoxications due to ethanol were decreasing in all countries in 2017 
compared to previous years. 
3.5. Toxicological findings 
 
The frequency of all positive findings of medicinal and illicit drugs and alcohol in each country in 
2017 in comparison with 2002, 2007 and 2012 are presented in Table 2. That table clearly shows 
that poly-drug use was widespread in all countries. The median number of drugs (excluding 
ethanol) per case in each country varied between 4 and 6 (with the highest in Sweden and Finland 
and lowest in Norway). The abuse, as in the earlier years, was characterised by traditional illicit 
drugs (heroin/morphine, cocaine, amphetamine, MDMA and THC), medicinal drugs 
(buprenorphine, methadone, tramadol, oxycodone and benzodiazepines) and alcohol. However, a 
wide variety of NPS, and especially the fentanyl analogues, were detected in all countries except 
Iceland. Ethanol was detected in all countries, with 7–47% of the cases being positive for ethanol. 
The percentage was highest in Finland and lowest in Iceland. The ethanol concentration was above 
0.5 mg/g in most these cases. 
3.5.1. Illicit and medicinal drugs 
Opioids were frequently detected in all countries (Table 2). Heroin/morphine was most often 
detected in cases in Norway and Sweden, while methadone was the most frequent drug in Denmark. 
Buprenorphine was the most frequent opioid in Finland, as was the case in earlier studies. The 
decrease in heroin/morphine-positive cases, which was replaced by a corresponding increase in 
methadone in Denmark, Norway and Sweden since 1997, has stopped. Denmark and Sweden saw a 
slight increase in heroin/morphine positive cases, but these cases continued to decrease in Norway. 
The frequency of methadone-positive cases decreased in all countries except Finland, which 
experienced an increase. Nevertheless, as in the earlier years, only a few cases were positive for 
heroin/morphine and methadone in Finland. Norway had a large increase in buprenorphine-positive 
cases, from 7% in 2012 to 21% 2017, and is now at the same level as Sweden (23%). The frequency 
of buprenorphine-positive cases was high and unchanged in Finland (54%). By contrast, only few 
 
cases were positive for buprenorphine in Denmark. Heroin/morphine, methadone and 
buprenorphine were detected in a few cases in Iceland. 
Tramadol and oxycodone were observed in all countries but most frequently in Finland. The 
frequency of oxycodone increased in all countries except Denmark, which had the lowest 
frequency. Few cases were positive for tramadol and oxycodone in Iceland. Newer designer 
fentanyl analogues were detected in all countries except Iceland. Many different fentanyl analogues 
(acryoylfentanyl, methoxyacetylfentanyl, furanylfentanyl etc.) were found primarily in Sweden 
(Table 2 footnotes). U-47700 a NPS with opioid effect was detected in a few cases in Finland and 
Sweden. 
The finding of amphetamine increased compared to 2012 in all countries except Denmark. The 
number nearly doubled in Norway and Sweden. Iceland showed the largest increase, and 
amphetamine was the most frequent drug detected in Iceland. Amphetamine was more frequently 
detected in Iceland compared to the other countries, followed by Finland. The frequency of 
methamphetamine increased in Finland from 9% to 20% and in Iceland from 0% to 27% while it 
decreased in Norway. Only a few methamphetamine-positive cases were seen in Sweden and 
Denmark. In turn, Denmark saw a large increase in cocaine-positive cases compared to 2012, as 
cocaine was found in nearly half (44%) of all cases in Denmark. Cocaine was detected in all 
countries. 
MDMA abuse increased in all countries and was most frequent in Finland and Iceland. Many 
different central stimulating NPS (Alpha-PVP, Alpha-PHP, 2-CB, 5CI-AB-PINACA etc.) were 
detected almost exclusively in Finland and Sweden. A single case of 5-APB was detected in 
Norway. GHB was detected to a lesser extent (1.5–5%) in Norway and Finland. Methylphenidate 
 
was found in all countries and 2–8% of the cases were positive for methylphenidate. Four cases 
(27%) were positive for methylphenidate in Iceland. 
Cannabis abuse has been frequent and unchanged through the years in all countries (34–41%) and 
remains one of the most frequently used drugs (Table 2). The z-hypnotics (zolpidem and zopiclone) 
were detected in all countries. Zopiclone was detected most frequently in Sweden (14%) with fewer 
cases (2.5–10%) in the other countries. Only a few cases (1–3%) were positive for zolpidem. 
Pregabalin and gabapentin were detected in all countries, especially pregabalin (8–42%). The 
highest percentage was seen in Finland (42%) followed by Sweden (30%). The frequency of cases 
with gabapentin varied from 4–14%, with the highest percentage seen in Finland (14%). 
Antidepressants and antipsychotics (one or more per case) were detected frequently in all countries. 
The percentages varied between 16 and 53%. Citalopram and mirtazapine were the most commonly 
used antidepressants, while olanzapine and quetiapine were the most frequently detected 
antipsychotics. 
3.5.2. Benzodiazepines 
The percentage of cases in which benzodiazepines (one or more per case) were found varied from 
73.5–88% in all countries. Benzodiazepines were therefore the most frequent drugs detected in fatal 
poisonings in all countries. Many different benzodiazepines were detected, especially in Sweden 
(Table 3). 
Clonazepam and diazepam were among the three most frequently detected benzodiazepines in all 
countries except Iceland, where clonazepam was not detected (Table 3). The increase in 
clonazepam use seen since 2002 continued in all countries, but to a lesser extent in Norway and 
Sweden. In 2017, clonazepam was the most frequently detected benzodiazepine in Denmark and 
Norway. In Finland, clonazepam shared the first place with diazepam. Cases with clonazepam and 
 
alprazolam doubled from 2012 to 2017 in Denmark. The increase in alprazolam use seen since 2002 
continued in Denmark and Sweden but stopped in Finland and Norway. Alprazolam was the most 
frequently detected benzodiazepine in Sweden and Iceland and the third most used in Finland and 
Norway in 2017. In Denmark, nitrazepam (14%) was the third most used benzodiazepine shortly 
followed by alprazolam (13%).  
Flunitrazepam, which was one of the most frequent benzodiazepines in Norway in 2002 and 2007 
and in Sweden in 2002, has almost disappeared. Only 2% of the fatal poisonings were positive for 
flunitrazepam in Sweden in 2017. 
A number of different NPS benzodiazepines were found, especially in Sweden (Table 3). Thirteen 
percent (53 cases) of the fatal poisonings in Sweden contained the NPS benzodiazepine 
norfludiazepam. Another NPS benzodiazepine, phenazepam, was detected in 10 cases in Finland 
and in three cases in Sweden and in one case in Iceland. Flubromazolam was detected in Denmark, 
Finland and Sweden in 1–2 cases. Etizolam was detected in 3–4 cases in Finland and Sweden.  
 
4. Discussion 
The definition used in this study for a drug addict was agreed upon by the Nordic working group in 
1984 and has been used in all subsequent papers [8-13]. The purpose of this definition was to focus 
on the problem of drug abusers applying an illicit route of administration, such as injection, or 
abusing the drugs listed in the international conventions from 1961 and 1971 [8]. 
Compared to the 2012 situation, the death rate increased in Finland, Iceland and Sweden but 
decreased Denmark and Norway, which had shown the highest death rates in previous years. 
Overall, the differences between the Nordic countries have levelled off over the years.  
 
Illicit drug abuse has changed over the years, but opioid overdose is still the main cause of death 
among fatally poisoned drug addicts. In 2017, a wide variety of fentanyl analogues were detected in 
most Nordic countries. Sweden experienced an epidemic of deaths due to fentanyl analogues, while 
the findings were more limited in Denmark, Finland and Norway, and no deaths occurred in 
Iceland. A report from the Swedish Police [14] described the course of the epidemic between 2015 
and 2018 and emphasised the crucial role of the local Internet vendors that were few in number but 
indirectly caused hundreds of deaths. This is an example of how a part of the illicit market has 
moved from the street to the Internet. It also shows how fast the drug market can change and how 
few criminals are able to supply NPS drugs to a large group of abusers. 
In this study, Denmark and Norway showed a similar drug profile. Both countries had 
heroin/morphine, methadone and a CNS stimulant (cocaine in Denmark and amphetamine in 
Norway) among the three most prevalent drugs, besides THC and benzodiazepines. Finland differed 
from those, having buprenorphine, pregabalin and amphetamine as the three most prevalent drugs. 
Sweden showed similarities with Denmark and Norway but also with Finland, having 
heroin/morphine and pregabalin as the two most prevalent drugs, while amphetamine and 
buprenorphine shared third place. It seems as the abuse of amphetamines has changed from 
methamphetamine to amphetamine in Norway.  
A recent study analysed the persistently high buprenorphine-related mortality in Finland [15]. The 
origins of buprenorphine abuse date back to the 1990s, when two general practitioners in Helsinki 
introduced buprenorphine unlawfully for the treatment of opioid addicts. Currently, most of the 
abused buprenorphine is illegally trafficked Subutex® tablets originating from France. Despite the 
presence of naloxone in Suboxone®, this product is also abused to a lesser extent. The percentage of 
parenteral Suboxone® users in which the pathologist has implicated buprenorphine in the cause of 
death was similar to that for parenteral Subutex® users [15]. 
 
Cocaine was previously rare in deaths in the north of Europe, but it has now made its appearance as 
a cause of death in all Nordic countries, and was the second most frequently drug detected in 
Denmark. This is in line with the fact that cocaine seizures in the EU reached record highs in 2017, 
with increased purity at the retail level [3]. MDMA also appeared as a marked cause of death in all 
Nordic countries. Similarly, in England and Wales [16], heroin/morphine and methadone continued 
to be the principal drugs involved in fatal poisonings, but a big increase in cocaine deaths and a 
steady increase in MDMA deaths was also found. Wastewater-based epidemiology from five 
Nordic capitals in 2016 has shown that cocaine use was still low compared with cities in the 
southern and western part of Europe, while MDMA and cocaine showed clear variations between 
weekdays and weekends, indicating recreational use during weekends [17]. 
Pregabalin and gabapentin have manifested themselves among components of poly-drug abuse, and 
these drugs were detected in all Nordic countries. Pregabalin was among the most frequently 
detected drugs in Finland and Sweden in both 2012 and 2017, and deaths from pregabalin were 
observed in these countries in both studies [13]. Pregabalin is prescribed to treat neuropathic pain, 
epilepsy and generalised anxiety disorder. It has been previously considered a drug with low abuse 
potential but more recent reports have demonstrated abuse and development of dependence [18-20]. 
Pregabalin at high doses possesses sedative effects like benzodiazepines, and consequently it adds 
to the respiratory depression caused by opioids. 
Antidepressants/antipsychotics were frequently detected in all countries except for Norway. Some 
illicit drugs can induce psychosis; however, individuals with psychiatric illnesses may use drugs as 
self-medication. The high prevalence of antidepressants/antipsychotics is also due to the fact that 
these drugs have considerable off-label use as hypnotics and anxiolytics in the treatment of addicts 
[13, 21]. 
 
A limitation of this study concerns the definition of the main intoxicant, since the following rule has 
been used in all studies: “if the cause of death cannot be ascribed to a single substance, the drug 
with the lowest group number is considered the main intoxicant”. This rule made sense in the earlier 
studies when heroin was the most widespread and problematic narcotic drug. However, as the drug 
situation has changed, this rule camouflages the influences of other drugs like buprenorphine as 
cause of death. This may affect the data presented in Table 1 and Figure 3. In future work, the 
groups may need to be reorganised for a better illustration of cause of death by including all opioids 
in Group I. Another issue concerns the target age group, which originally consisted of drug addicts 
that died at the age of 15–35 years [8]. The situation has changed, as drug addicts live longer; 
consequently, the age group in this study was extended to 14–70 years. 
The series of the Nordic studies on fatal drug poisonings, commenced in 1984, is unique since the 
same definition for a drug addict has been used in all studies and by all Nordic countries. To our 
knowledge, no similar studies exist in the literature. The current data is easily compared with earlier 
data, as the results have been presented, with some minor modifications, in similar tables and 
figures [9-13]. During the present study period, the post-mortem toxicology rate among all deaths 
was approximately 12% in Finland, 7% in Iceland, 5% in Sweden and Norway and 2% in Denmark. 
However, the study material is assumed to be almost population based, since comprehensive 
toxicology is performed in suspected cases of fatal poisonings in all the Nordic countries. Even in 
Denmark, with the lowest autopsy rate, all drug related deaths are, by law, undergoing a 






As in the previous years, abuse trends and patterns varied among the Nordic countries in 2017. 
Finland, in particular, had a different drug profile compared to the other countries. Opioids were 
still the main cause of death in all countries, but over the years the proportion of opioid deaths has 
decreased in all countries except Sweden. Instead, deaths from CNS stimulants like cocaine, 
amphetamine and MDMA have increased.  
NPS were detected in all countries except Iceland. Fentanyl analogues appeared for the first time 
and were seen in all countries except Iceland. NPSs were most frequent in Sweden and changed 
from being the lowest cause of death in 2012 to the second highest cause of death in 2017. Abuse of 
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Figure1 Legend; Fatal poisonings among drug addicts in 1991, 1997, 2002, 2007 and 2017. Number 
of deaths per 100,000 inhabitants in 2017 was as follows: Denmark, 4.29; Finland, 5.84; Iceland, 












































     
     
                   
               Figure 2 legend;  


















































Figure 3 Legend: 
Cause of death by opioids. Number of deaths per 100,000 inhabitants in 1991, 1997, 2002, 2007, 2012 and 2017. The years: 1991-2002 presents the age 





















































































 Denmark, n Finland, n 
 
Norway, n Sweden, n Iceland, n 
 2002 2007 2012 2017 2002 2007 2012 2017 2002 2007 2012 2017 2002 2007 2012 2017 2007 2012 2017 
Group I drugs suma 163 209 169 146 43 52 60 70 210 206 156 155 107 151 176 292 8 7 9 
Heroin/morphine 76 75 51 40 9 2 3 2 168 160 86 69 90 94 55 110 3 2 1 
Methadone 72 116 111 85 0 16 8 13 34 37 56 46 5 22 75 59 3 0 1 
Codeine 0 0 1 0 11 8 12 6 4 2 2 4 1 0 0 0 0 1 0 
Cocaine 1 6 4 15 2 0 0 6 1 1 0 6 1 1 2 6 0 0 2 
Fentanyl   0 0 2 3 7 12 3   3 7 0 10 27 16 2 0 2 
Tramadol 5 2 1 1 9 14 18 16 0 2 4 6 2 12 8 21 0 3 0 
Oxycodone 0 3 0 1 1 4 6 19 0 2 9 14 0 5 9 12 0 1 2 
                    
Group II drugs sumb 3 8 5 6 13 10 32 45 9 13 21 21 18 16 20 11 1 1 5 
Amphetamine 2 6 2 2 12 8 13 14 9 9 4 7 16 11 8 3 0 0 1 
Methamphetamine 0 0 0 0    8   10 7 1 0 1 1 0 0 1 
MDMA 1 1 2 4 1 1 1 10   1 3 0 2 0 6 0 0 2 
GHB  0 1 0  1 12 7  3 4 3 1 2 4 0 0 0 0 
Methylphenidate  0 0 0  0 1 0  0 0 0  0 1 0 1 1 1 
                    
Group III drugs sumc 1 4 3 6 16 45 57 72 4 11 13 20 3 12 42 75 0 0 1 
Buprenorphine  1 0 2 16 32 42 48 1 6 5 13  8 35 61   1 
Pregabalin  0 0 0   10    9   0 0  1   3 3   0 
Gabapentine  0 0 0   0 1  0 0 0  0 0 1   0 
                    
Group IV drugs sumd 8 5 11 4 22 22 13 16 9 7 3 7 8 15 17 30 1 3 0 
Ethanol 0 1 1 0 7 13 7 6 2 3 1 1 0 1 8 4 0 1  
Total 175 226 188 162 94 129 162 202 232 236 194 203 136 194 255 408 10 11 15 
 
2017 Comments: Denmark: a Acryloylfentanyl: 1, Methoxyacetylfentanyl: 1; c Alprazolam: 1, Clonazepam: 2, Flubromazolam: 1; dAntidepressant/antipsychotic: 3. 
 
Finland: aCarfentanil: 2, Furanylfentanyl: 1, U-47700: 2; b 3-MeO-PCP: 1, alpha-PVP: 3, THC: 2; cAlprazolam: 3, Clonazepam: 3, Oxazepam: 2, Diazepam: 
1, Chlordiazepoxide: 1, Zolpidem: 1, zopiclone: 2; dAntidepressants/antipsychotics: 3. 
 
Norway: a Carfentanil: 1, Mitragynine: 1, Ethylmorphine:1; b5-APB:1; cAlprazolam: 1, Clonazepam: 4, Diazepam: 1; d Antidepressants/antipsychotics: 4, 
Lighter gas:1, methanol: 1. 
 
Sweden: aCyclopropylfentanyl: 52, Furanylfentanyl: 4, Acryloylfentanyl: 4, Methoxyacetylfentanyl: 3, Carfentanil: 2, 4F-isobutyrfentanyl: 1,   
Tetrahydrofuranfentanyl: 1, U-47700: 1; b Ethylphenidate: 1; c Alprazolam: 3, Clonazepam: 1, Flunitrazepam: 1, Norfludiazepam: 3, Zolpidem: 2;  




Table 1 Legend; Fatal poisoning in medico-legally-examined drug addict deaths in the Nordic countries in 2017 in comparison with 2002, 2007 and 
2012 grouped according to the assumed main cause of death, n = number of fatal poisonings in the different groups. 
 Denmark Finland 
 
Norway Sweden Iceland 
 2002 2007 2012 2017 2002 2007 2012 2017 2002 2007 2012 2017 2002 2007 2012 2017 2002 2007 2012 2017 
Number of cases 175 226 188 162 94 129 162 202 232 236 194 203 136 194 255 408 6 10  11 15 
 % % % % % % % % % % % % % % % % % % % % 
Group I drugs                     
Heroin/morphine 48 40 30 35 35 3 6 5 78 71 45 37 69 49 29 32 50 30 27 20 
Methadone 53 61 71 65 2 13 7 12 19 21 34 29 7 14 32 17 17 30 0 7 
Codeine 15 8 9 4 27 17 15 9 6 6 8 11 9 2 2 1 17 20 27 20 
Cocaine 15 15 19 44 2 1,5 0 6 2 8 5 5.9 4 3 5 10 33 10 0 33 
Fentanyl   0.5 5  7 9 2  0 3 4.9  5 11 5  20 0 13 
Tramadol 3 6 6 3 11 18 15 16 0 3 3 7.9 7 12 7 10 0 20 36 20 
Oxycodone 0 2 3 4 1 8 6 15 0 2 5 9.9 0 3 5 8  0 9 20 
Other Group I drugsa 17 5.8 5 2.5 12 1.5 2 4 2 0.8 0.5 2.5 11 6 0.4 18 17 0 0 7 
                     
Group II drugs                     
Amphetamine 9 10 10 11 23 25 22 32 30 15 13 25 29 32 14 23 33 40 18 60 

















































Tetrahydrocannabinol 36 26 34 41 37 36 38 40 24 21 31 39 21 22 25 34 17 0 36 13 
Other Group II drugsb  0.4 2.0 1  0 15 11  0.4 8 0.5  0.5 10 4  0 9 0 
                     
Group III drugs                     
Benzodiazepinesc 41 55 71 73.5 71 82 88 88 67 70 80 75 51 59 71 74     33 40 27 80 
Zopiclone  3.5 4 2.5  6 4 6  6 7 9.9  8 16 14   9 7 



























Buprenorphine 0.6 2 4 8 19 40 54 54 2 6 7 21 2 10 24 23    13 
Other Group III drugsd  0 0 0  0 0 0  3.2 0 0 9 3 0 0   0 7 
                     
Group IV drugs                      
Ethanol  total 34 34 36 20 47 47 44 47 21 30 16 11 35 26 24 24 0 10 18 7 
Ethanol >0.50 mg/g 25 29 18 11 40 41 34 30 16 22 11 8.9 23 20 16 15 0 10 18 7 












































2017 comments:  Denmark: aKetobemidone: 0.6%, Hydromorphone: 0.6%;Acryloylfentanyl: 0.6%, Methoxyacetylfentanyl: 0.6%; b Ketamine: 1%,; cFlubromazolam: 0.6% 
Finland: a Dextromethorphan 0.5%, U-47700 1%, Carfentanil: 1%, Acetylfentanyl: 1%, Furanylfentanyl: 0.5%; b Alpha-PVP 6%, Ketamine: 2.5%;  
2F-Methamphetamine: 0.5%, 5-MeO-MIPT: 0.5%, MDA: 0.5%, BZP: 0.5%, 2-CB 0.5%; cEtizolam: 1.5%, Flubromazolam: 1% 
Norway: aAcetylfentanyl: 0.5%, Ethyl morphine: 1.0%, Carfentanil: 0.5%, Ketobemidone: 0.5%, Mitragynine: 0.5%, Tapentadol: 0.5%; b5-APB: 0.5%.  
Sweden: aCyclopropylfentanyl: 13%, Furanylfentanyl: 1%, Acryloylfentanyl: 1%, Methoxyacetylfentanyl: 1%, Carfentanil: 0.5%, Tetrahydrofuranfentanyl: 0.5%;  
U-47700: 0.5%, Ethylmorphine: 0.5%, 4F-Isobutyrfentanyl: 0.2%, Tetrahydrofuranfentanyl: 0.2%; bAlpha-PHP: 1%, Alpha-PiHP: 1%, N-isopropylnorhexedrone: 1%,  
4F-N-Ethylpentedrone: 0.5%, 5Cl-AB-PINACA: 0.2%, N-Ethyl-4methylnorpentedrone: 0.2%, Ethylphenidate: 0.2%, 4F-Ethylphenidate: 0.2%. cNorfludiazepam: 13%, 
Etizolam: 1%, Phenazepam: 0.7%, Flubromazolam: 0.2%.                                                  
Iceland: aKetobemidone. dPhenobarbital. 
 
Table 2 Legend; Analytical findings for drugs and poisons in medico-legally-examined fatal poisonings in drug addict deaths in the Nordic countries in 2017 in comparison with 2002, 2007 
and 2012. 
 
 Denmark Finland Norway Sweden Iceland 
 2002 2007 2012 
 
2017 2002 2007 2012 2017 2002 2007 2012 2017 2002 2007 2012 2017 2002 2007 2012 2017 
Number of cases 175 226 188 162 94 129 162 202 232 236 194 203 136 194 255 408 6 10 11 15 
                     
Diazepam (%) 35 26 34 29 50 63 54 47 30 35 33 28 25 35 25 20 17 20 9 7 
Clonazepam (%) 3 12 22 45 1 5 37 47 13 20 50 53 4 15 27   28 0 0  0 
Alprazolam (%) 4.5 4 7 13 15 24 36 31 3 12 19 19 4 18 39   45 0 10  40 
Nitrazepam (%) 3 9 18 14 0 0  0 6 19 10 7.9 6 4 6   3 0 0  0 
Bromazepam (%) 8 12 16 10 0 0  0     0 0 0.4   0.2     7 
Flunitrazepam (%)* 1 7 6 0 0 0 0 0 48 27 6  21 4 4   3 0 0  0 
Temazepam (%) 0 0 0 0 44 38 17 10     0 0 0   0    0 
Oxazepam (%) 7 5 7 2 38 48 16 13 2 11 6 11 2 1.6 4   2 0 0 9 13 
Chlordiazepoxid(%) 4 11 12 9 3 4  3.5     0 0 0   0 17 10 9 7 
Midazolam (%)  0 2 0.6   4.3 5    1.5      0.2    0 
Phenazepam (%)**  0 2.7 0   1.2 5  1 1  0 0 0.8   0.7    7 
Lorazepam (%)  0.5 1.0 0 3 2  3.5     0.7 0 0   1    0 
Triazolam (%)  0 0 0    0       0.4   0    0 
Etizolam (%)   0 0    1.5   0.5    1   1    0 
Flubromazolam (%)    0.6    1          0.2     
Norfludiazepam (%)                  13     
* 7-aminodesmethylflunitrazepam included, ** 3-OH-phenazepam included 
Table 3 Legend; Frequency of benzodiazepines in medico-legally examined drug addict deaths in the Nordic countries in 2017 in comparison 
with 2002, 2007 and 2012. 
 
